| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
88,894 |
78,758 |
$51.59M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
104,322 |
96,326 |
$39.92M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
47,924 |
42,921 |
$33.32M |
| G0378 |
Hospital observation service, per hour |
16,024 |
13,096 |
$13.01M |
| H0035 |
Mental health partial hospitalization, treatment, less than 24 hours |
39,168 |
3,497 |
$12.71M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
30,885 |
29,404 |
$7.44M |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
18,132 |
15,555 |
$5.08M |
| 59025 |
Fetal non-stress test |
10,622 |
4,035 |
$3.82M |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
22,326 |
17,350 |
$3.44M |
| 90837 |
Psychotherapy, 53 minutes with patient |
28,805 |
12,923 |
$2.81M |
| A0434 |
Specialty care transport (sct) |
5,537 |
4,933 |
$2.59M |
| A0425 |
Ground mileage, per statute mile |
53,778 |
42,663 |
$1.99M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
4,587 |
4,440 |
$1.92M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
992 |
955 |
$1.58M |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
60,066 |
53,341 |
$1.35M |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
22,457 |
6,016 |
$1.24M |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
1,965 |
1,879 |
$1.18M |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
2,755 |
2,687 |
$1.14M |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
699 |
689 |
$1.10M |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
459 |
456 |
$1.08M |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
34,342 |
12,513 |
$1.00M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
15,720 |
15,026 |
$974K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
6,454 |
6,337 |
$841K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
43,091 |
38,257 |
$815K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
1,200 |
1,159 |
$811K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
25,880 |
8,172 |
$792K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
7,136 |
6,955 |
$779K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
536 |
512 |
$775K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
9,318 |
8,755 |
$770K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
67,972 |
16,437 |
$764K |
| 76830 |
Ultrasound, transvaginal |
5,981 |
5,858 |
$746K |
| 95806 |
|
514 |
511 |
$733K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
5,203 |
5,081 |
$676K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
24,093 |
8,868 |
$675K |
| 71046 |
Radiologic examination, chest; 2 views |
39,534 |
37,555 |
$590K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
1,145 |
1,133 |
$581K |
| OP710 |
|
13,135 |
12,536 |
$574K |
| 76801 |
|
6,914 |
6,390 |
$476K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
543 |
535 |
$472K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
6,495 |
4,207 |
$437K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
14,451 |
12,672 |
$434K |
| 93970 |
|
2,280 |
2,199 |
$428K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
169 |
169 |
$418K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
18,376 |
11,309 |
$412K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
8,305 |
8,009 |
$409K |
| 90791 |
Psychiatric diagnostic evaluation |
3,466 |
2,856 |
$393K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
30,341 |
27,003 |
$393K |
| 93971 |
|
3,555 |
3,399 |
$363K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
5,556 |
4,831 |
$358K |
| 90834 |
Psychotherapy, 45 minutes with patient |
4,832 |
3,209 |
$356K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
21,784 |
20,400 |
$355K |
| OP279 |
|
26,795 |
23,267 |
$352K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
199 |
196 |
$350K |
| 70450 |
Computed tomography, head or brain; without contrast material |
18,194 |
16,936 |
$346K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
6,062 |
5,945 |
$340K |
| 47562 |
|
155 |
151 |
$327K |
| 36415 |
Collection of venous blood by venipuncture |
134,109 |
101,092 |
$327K |
| A0433 |
Advanced life support, level 2 (als 2) |
882 |
821 |
$319K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
26,922 |
24,137 |
$312K |
| 76770 |
|
3,033 |
2,965 |
$294K |
| 77066 |
Tomosynthesis, mammo |
1,551 |
1,535 |
$292K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
11,100 |
9,163 |
$291K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
21,297 |
19,077 |
$288K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
76,350 |
63,848 |
$287K |
| 71250 |
|
2,665 |
2,582 |
$284K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
2,821 |
2,729 |
$283K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
9,873 |
9,204 |
$281K |
| 95811 |
|
181 |
179 |
$277K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
109,395 |
87,787 |
$270K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
2,076 |
2,050 |
$264K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,580 |
1,513 |
$255K |
| 87631 |
|
8,519 |
8,032 |
$253K |
| 94760 |
|
137,762 |
114,242 |
$253K |
| 94060 |
|
962 |
951 |
$243K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
2,622 |
2,088 |
$241K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
1,186 |
1,155 |
$240K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
5,003 |
4,865 |
$229K |
| 97161 |
|
6,054 |
5,751 |
$222K |
| 76536 |
|
2,443 |
2,418 |
$222K |
| 80053 |
Comprehensive metabolic panel |
41,494 |
36,643 |
$221K |
| 76642 |
|
2,546 |
2,493 |
$220K |
| 93880 |
|
1,027 |
989 |
$213K |
| 71045 |
Radiologic examination, chest; single view |
24,995 |
22,706 |
$205K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,537 |
2,783 |
$204K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
5,021 |
4,783 |
$198K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
12,046 |
10,832 |
$186K |
| 97802 |
|
1,647 |
1,613 |
$185K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
14,020 |
13,421 |
$185K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
14,024 |
13,427 |
$183K |
| 73564 |
|
7,704 |
7,364 |
$183K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
7,576 |
7,073 |
$181K |
| OP272 |
|
9,549 |
8,890 |
$175K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,626 |
1,568 |
$168K |
| A0428 |
Ambulance service, basic life support, non-emergency transport, (bls) |
8,902 |
7,289 |
$165K |
| 77065 |
Tomosynthesis, mammo |
1,399 |
1,335 |
$165K |
| 93975 |
|
3,690 |
3,556 |
$160K |
| 73630 |
|
9,564 |
9,117 |
$159K |
| 73221 |
|
246 |
242 |
$156K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
13,727 |
12,749 |
$155K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
228 |
223 |
$153K |
| 93041 |
|
24,424 |
21,706 |
$153K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
3,622 |
3,491 |
$150K |
| 93925 |
|
431 |
414 |
$150K |
| 36000 |
|
22,972 |
21,472 |
$142K |
| 97162 |
|
4,339 |
4,095 |
$139K |
| 10060 |
|
1,882 |
1,818 |
$133K |
| 76820 |
|
1,973 |
1,354 |
$133K |
| 82962 |
|
36,411 |
25,319 |
$125K |
| OP259 |
|
126,666 |
98,765 |
$124K |
| 86901 |
|
12,499 |
11,538 |
$122K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
7,599 |
7,323 |
$121K |
| 97010 |
|
27,957 |
8,855 |
$120K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,220 |
1,841 |
$117K |
| 72110 |
|
3,612 |
3,488 |
$116K |
| 73130 |
|
7,529 |
7,216 |
$111K |
| 80076 |
|
42,423 |
38,109 |
$111K |
| 90832 |
Psychotherapy, 30 minutes with patient |
2,167 |
1,469 |
$106K |
| 76818 |
|
852 |
602 |
$102K |
| G2251 |
Brief communication technology-based service, e.g. virtual check-in, by a qualified health care professional who cannot report evaluation and management services, provided to an established patient, not originating from a related service provided within the previous 7 days nor leading to a service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of clinical discussion |
1,740 |
1,304 |
$100K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
4,103 |
3,565 |
$100K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
6,301 |
5,922 |
$100K |
| 73030 |
|
6,038 |
5,788 |
$97K |
| 84484 |
|
22,063 |
17,710 |
$96K |
| 93017 |
|
294 |
290 |
$91K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
1,774 |
373 |
$90K |
| J3490 |
Unclassified drugs |
37,727 |
27,598 |
$90K |
| 73610 |
|
7,418 |
7,091 |
$88K |
| 84443 |
Thyroid stimulating hormone (TSH) |
7,620 |
7,193 |
$86K |
| 70486 |
|
2,630 |
2,536 |
$84K |
| 81003 |
|
71,304 |
65,024 |
$84K |
| 97116 |
|
6,954 |
4,145 |
$82K |
| 83880 |
|
11,623 |
10,471 |
$82K |
| 72141 |
|
199 |
196 |
$82K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
30,607 |
28,635 |
$82K |
| 73110 |
|
5,012 |
4,747 |
$81K |
| 83690 |
|
36,826 |
33,322 |
$80K |
| 97803 |
|
1,059 |
1,027 |
$78K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,509 |
1,331 |
$78K |
| 86850 |
|
10,468 |
9,689 |
$74K |
| 83735 |
|
36,249 |
30,373 |
$65K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
4,405 |
4,085 |
$65K |
| 70491 |
|
786 |
760 |
$65K |
| 72197 |
|
63 |
62 |
$64K |
| 86900 |
|
12,466 |
11,511 |
$62K |
| 76870 |
|
1,261 |
1,210 |
$62K |
| 85610 |
|
19,501 |
17,069 |
$59K |
| 97535 |
Self-care/home management training, each 15 minutes |
7,811 |
5,328 |
$57K |
| 0002A |
|
1,708 |
1,695 |
$55K |
| 80061 |
Lipid panel |
4,885 |
4,697 |
$55K |
| 81001 |
|
42,801 |
39,372 |
$54K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
31,183 |
27,432 |
$54K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
4,290 |
3,959 |
$54K |
| OP278 |
|
76 |
72 |
$54K |
| 73502 |
|
2,995 |
2,871 |
$53K |
| 86480 |
|
967 |
952 |
$52K |
| 77080 |
|
646 |
626 |
$51K |
| 0001A |
|
1,744 |
1,726 |
$50K |
| 97165 |
|
2,379 |
2,248 |
$50K |
| 12001 |
|
2,150 |
2,087 |
$50K |
| 85027 |
|
9,667 |
8,700 |
$49K |
| 72050 |
|
972 |
947 |
$45K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
140 |
123 |
$44K |
| 92567 |
|
561 |
555 |
$44K |
| OP250 |
|
24,688 |
20,814 |
$43K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
2,144 |
2,109 |
$41K |
| 94729 |
|
943 |
931 |
$41K |
| 73590 |
|
3,386 |
3,179 |
$40K |
| 87581 |
|
3,678 |
3,545 |
$40K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
212 |
212 |
$40K |
| 74018 |
|
2,204 |
2,130 |
$40K |
| 87486 |
|
3,678 |
3,545 |
$40K |
| 12011 |
|
1,685 |
1,645 |
$40K |
| 83605 |
|
7,846 |
7,056 |
$39K |
| J1644 |
Injection, heparin sodium, per 1000 units |
5,289 |
2,838 |
$39K |
| 85730 |
|
14,975 |
13,745 |
$38K |
| 97166 |
|
1,994 |
1,849 |
$38K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
4,292 |
4,062 |
$37K |
| 80306 |
|
1,813 |
1,710 |
$37K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
6,757 |
5,439 |
$36K |
| 92523 |
|
664 |
638 |
$35K |
| 73080 |
|
2,876 |
2,728 |
$34K |
| J2704 |
Injection, propofol, 10 mg |
11,968 |
11,438 |
$34K |
| 93458 |
|
12 |
12 |
$33K |
| 77336 |
|
310 |
129 |
$33K |
| 87186 |
|
6,875 |
6,452 |
$33K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
147 |
147 |
$33K |
| 84702 |
|
6,675 |
5,614 |
$33K |
| 72100 |
|
1,189 |
1,152 |
$32K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
14,124 |
13,113 |
$32K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
5,111 |
4,601 |
$31K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
31,540 |
26,912 |
$31K |
| 76821 |
|
260 |
201 |
$31K |
| 87040 |
|
3,811 |
3,417 |
$30K |
| 97150 |
Therapeutic procedure(s), group (2 or more individuals) |
5,947 |
1,827 |
$30K |
| 74022 |
|
1,445 |
1,403 |
$30K |
| 90714 |
|
4,973 |
4,829 |
$30K |
| 73090 |
|
3,050 |
2,821 |
$29K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
16,668 |
15,915 |
$29K |
| 12002 |
|
1,014 |
990 |
$29K |
| 96376 |
|
4,214 |
3,793 |
$28K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
10,080 |
9,591 |
$28K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
11,500 |
10,755 |
$27K |
| 72114 |
|
428 |
415 |
$27K |
| 74183 |
|
38 |
36 |
$26K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
893 |
877 |
$26K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,785 |
4,635 |
$26K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
9,792 |
8,116 |
$25K |
| C1776 |
Joint device (implantable) |
22 |
22 |
$23K |
| 80320 |
|
8,062 |
6,865 |
$23K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
5,233 |
5,158 |
$22K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
10,938 |
10,634 |
$22K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
26,991 |
24,296 |
$21K |
| 82247 |
|
2,640 |
1,839 |
$21K |
| 81025 |
|
24,845 |
23,010 |
$21K |
| 84703 |
|
19,748 |
18,273 |
$21K |
| 70496 |
|
502 |
473 |
$20K |
| 94727 |
|
643 |
640 |
$20K |
| 70498 |
|
642 |
605 |
$20K |
| 87077 |
|
5,652 |
5,286 |
$19K |
| 92588 |
|
121 |
119 |
$19K |
| 88342 |
|
1,405 |
1,326 |
$19K |
| C1769 |
Guide wire |
1,336 |
1,135 |
$19K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
859 |
823 |
$19K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
12,919 |
10,511 |
$18K |
| 82803 |
|
4,046 |
3,660 |
$18K |
| 82248 |
|
3,809 |
3,194 |
$18K |
| 51702 |
|
671 |
640 |
$18K |
| 97163 |
|
650 |
611 |
$17K |
| 73552 |
|
1,502 |
1,411 |
$17K |
| 76881 |
|
118 |
113 |
$17K |
| OP270 |
|
451 |
340 |
$16K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
4,287 |
3,830 |
$16K |
| 76641 |
|
177 |
175 |
$16K |
| 72070 |
|
529 |
519 |
$16K |
| 73560 |
|
692 |
651 |
$15K |
| 86803 |
|
844 |
826 |
$15K |
| 36430 |
|
445 |
350 |
$15K |
| 87081 |
|
7,629 |
7,399 |
$14K |
| 94726 |
|
280 |
273 |
$14K |
| J2060 |
Injection, lorazepam, 2 mg |
5,087 |
4,295 |
$14K |
| 73060 |
|
1,410 |
1,355 |
$14K |
| 76000 |
|
945 |
896 |
$14K |
| 97016 |
|
1,408 |
338 |
$14K |
| 82550 |
|
3,580 |
3,208 |
$14K |
| 92579 |
|
64 |
63 |
$13K |
| 84100 |
|
4,616 |
4,141 |
$13K |
| J7050 |
Infusion, normal saline solution, 250 cc |
3,000 |
2,758 |
$13K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
15 |
13 |
$13K |
| 95816 |
|
38 |
37 |
$12K |
| 90675 |
|
35 |
15 |
$12K |
| 0004A |
|
392 |
384 |
$12K |
| 82330 |
|
3,295 |
3,030 |
$12K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
3,617 |
2,135 |
$12K |
| 80329 |
|
1,837 |
1,733 |
$12K |
| Q3014 |
Telehealth originating site facility fee |
646 |
342 |
$12K |
| 88304 |
|
1,784 |
1,741 |
$11K |
| 85055 |
|
1,570 |
1,252 |
$11K |
| 88307 |
|
453 |
417 |
$11K |
| 71271 |
|
107 |
96 |
$11K |
| 82375 |
|
4,136 |
3,745 |
$11K |
| A4311 |
Insertion tray without drainage bag with indwelling catheter, foley type, two-way latex with coating (teflon, silicone, silicone elastomer or hydrophilic, etc.) |
553 |
523 |
$11K |
| 81329 |
|
97 |
97 |
$11K |
| 97014 |
|
2,511 |
889 |
$11K |
| 72220 |
|
324 |
318 |
$10K |
| 86787 |
|
815 |
807 |
$10K |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
161 |
161 |
$10K |
| 84439 |
|
1,177 |
1,108 |
$10K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
6,693 |
5,453 |
$10K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
198 |
195 |
$10K |
| 29075 |
|
361 |
357 |
$10K |
| 88300 |
|
554 |
521 |
$9K |
| 82947 |
|
3,529 |
3,145 |
$9K |
| J1630 |
Injection, haloperidol, up to 5 mg |
2,714 |
2,313 |
$9K |
| 80165 |
|
1,252 |
1,083 |
$9K |
| 87147 |
|
7,737 |
7,510 |
$9K |
| 95819 |
|
42 |
42 |
$9K |
| 87210 |
|
11,647 |
10,952 |
$8K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
507 |
487 |
$8K |
| 0071A |
|
223 |
216 |
$8K |
| 87070 |
|
2,670 |
2,634 |
$8K |
| 83050 |
|
4,136 |
3,746 |
$8K |
| 72195 |
|
14 |
13 |
$8K |
| 0072A |
|
205 |
201 |
$8K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
5,491 |
3,931 |
$8K |
| 73140 |
|
945 |
906 |
$7K |
| 73700 |
|
70 |
67 |
$7K |
| 81401 |
|
97 |
97 |
$7K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
2,727 |
2,460 |
$7K |
| 87340 |
|
1,234 |
1,218 |
$7K |
| 82270 |
|
1,353 |
1,316 |
$7K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
5,310 |
4,654 |
$7K |
| 76813 |
|
64 |
51 |
$6K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
679 |
529 |
$6K |
| A0390 |
Als mileage (per mile) |
1,791 |
1,238 |
$6K |
| 73562 |
|
228 |
226 |
$6K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
1,177 |
858 |
$6K |
| 85018 |
|
4,124 |
3,716 |
$6K |
| 29405 |
|
174 |
172 |
$6K |
| 73620 |
|
370 |
359 |
$6K |
| 29540 |
|
382 |
376 |
$6K |
| 80074 |
|
189 |
189 |
$6K |
| 36600 |
|
684 |
647 |
$5K |
| 84436 |
|
884 |
866 |
$5K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
383 |
317 |
$5K |
| 82607 |
|
1,003 |
946 |
$5K |
| 72040 |
|
194 |
186 |
$5K |
| 86140 |
|
3,189 |
2,990 |
$5K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
12,414 |
10,587 |
$5K |
| 74174 |
|
88 |
83 |
$5K |
| 85379 |
|
3,551 |
3,439 |
$5K |
| 83540 |
|
1,444 |
1,361 |
$5K |
| 29581 |
|
79 |
24 |
$5K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
12 |
12 |
$5K |
| 84132 |
|
3,029 |
2,780 |
$5K |
| 84295 |
|
2,951 |
2,707 |
$4K |
| 73100 |
|
252 |
225 |
$4K |
| 87205 |
|
675 |
649 |
$4K |
| 82728 |
|
638 |
601 |
$4K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
128 |
128 |
$4K |
| 82435 |
|
2,951 |
2,705 |
$4K |
| OP229 |
|
84 |
69 |
$4K |
| 73120 |
|
221 |
204 |
$4K |
| 85652 |
|
3,033 |
2,866 |
$4K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
2,840 |
2,434 |
$4K |
| J1756 |
Injection, iron sucrose, 1 mg |
78 |
38 |
$4K |
| J2790 |
Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) |
67 |
65 |
$4K |
| 94761 |
|
952 |
892 |
$4K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
6,007 |
5,433 |
$4K |
| 85384 |
|
1,401 |
1,221 |
$4K |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
345 |
326 |
$4K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
28 |
26 |
$4K |
| 84479 |
|
654 |
640 |
$4K |
| 71101 |
|
189 |
187 |
$4K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
2,794 |
2,617 |
$4K |
| 0054A |
|
126 |
116 |
$4K |
| 29130 |
|
442 |
432 |
$4K |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
7,802 |
6,513 |
$4K |
| 82010 |
|
2,023 |
1,810 |
$4K |
| 86923 |
|
302 |
267 |
$3K |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
558 |
533 |
$3K |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
501 |
489 |
$3K |
| 36416 |
|
898 |
637 |
$3K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
328 |
317 |
$3K |
| 70220 |
|
68 |
65 |
$3K |
| 70360 |
|
218 |
213 |
$3K |
| 0052A |
|
87 |
86 |
$3K |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
1,828 |
1,611 |
$3K |
| 86618 |
|
316 |
302 |
$3K |
| 73600 |
|
190 |
180 |
$3K |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
848 |
547 |
$3K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
13,773 |
12,704 |
$3K |
| 83615 |
|
1,200 |
1,050 |
$3K |
| 88142 |
|
131 |
129 |
$3K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
4,587 |
4,048 |
$3K |
| J3360 |
Injection, diazepam, up to 5 mg |
616 |
571 |
$3K |
| 86762 |
|
821 |
813 |
$3K |
| 96367 |
|
231 |
216 |
$3K |
| 72082 |
|
26 |
26 |
$3K |
| 19083 |
|
12 |
12 |
$2K |
| OP299 |
|
35 |
34 |
$2K |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
196 |
192 |
$2K |
| J8540 |
Dexamethasone, oral, 0.25 mg |
4,836 |
4,643 |
$2K |
| 92587 |
|
16 |
15 |
$2K |
| 97022 |
|
700 |
214 |
$2K |
| A4344 |
Indwelling catheter, foley type, two-way, all silicone or polyurethane, each |
180 |
175 |
$2K |
| J1940 |
Injection, furosemide, up to 20 mg |
1,158 |
821 |
$2K |
| 84156 |
|
1,881 |
1,592 |
$2K |
| 84550 |
|
1,490 |
1,315 |
$2K |
| 86592 |
|
2,505 |
2,450 |
$2K |
| 73070 |
|
179 |
163 |
$2K |
| 82570 |
|
669 |
641 |
$2K |
| G8987 |
Self care functional limitation, current status, at therapy episode outset and at reporting intervals |
188 |
185 |
$2K |
| L2999 |
Lower extremity orthoses, not otherwise specified |
2,173 |
1,975 |
$2K |
| 82746 |
|
496 |
463 |
$2K |
| 82140 |
|
915 |
784 |
$2K |
| A4338 |
Indwelling catheter; foley type, two-way latex with coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each |
244 |
231 |
$2K |
| J1790 |
Injection, droperidol, up to 5 mg |
1,110 |
945 |
$2K |
| 83020 |
|
291 |
291 |
$2K |
| A4648 |
Tissue marker, implantable, any type, each |
75 |
64 |
$2K |
| 73000 |
|
86 |
81 |
$2K |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
1,157 |
1,109 |
$2K |
| 0003A |
|
60 |
60 |
$2K |
| 76882 |
|
49 |
45 |
$2K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
337 |
296 |
$2K |
| 77062 |
|
845 |
794 |
$2K |
| 82150 |
|
450 |
434 |
$2K |
| 51701 |
|
86 |
83 |
$1K |
| 87807 |
|
277 |
271 |
$1K |
| 82533 |
|
40 |
40 |
$1K |
| 0051A |
|
42 |
40 |
$1K |
| 99152 |
|
167 |
160 |
$1K |
| 72131 |
|
15 |
15 |
$1K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
104 |
104 |
$1K |
| 73503 |
|
158 |
153 |
$1K |
| J2760 |
Injection, phentolamine mesylate, up to 5 mg |
318 |
271 |
$1K |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
74 |
70 |
$1K |
| 72170 |
|
69 |
65 |
$1K |
| 87071 |
|
893 |
823 |
$1K |
| 80185 |
|
30 |
26 |
$1K |
| 84145 |
|
221 |
207 |
$1K |
| J3480 |
Injection, potassium chloride, per 2 meq |
1,513 |
1,226 |
$1K |
| 29515 |
|
85 |
85 |
$1K |
| 82043 |
|
371 |
354 |
$1K |
| 29530 |
|
199 |
192 |
$1K |
| 96368 |
|
152 |
151 |
$1K |
| 99153 |
Mod sedat endo service >5yrs |
105 |
101 |
$1K |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
797 |
763 |
$1K |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
95 |
90 |
$1K |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
167 |
166 |
$1K |
| 97018 |
|
663 |
195 |
$1K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
37 |
36 |
$1K |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
3,112 |
2,531 |
$1K |
| OP258 |
|
918 |
812 |
$988.48 |
| J1956 |
Injection, levofloxacin, 250 mg |
27 |
25 |
$973.30 |
| OP637 |
|
8,678 |
5,481 |
$944.48 |
| 80354 |
|
179 |
167 |
$874.75 |
| 90686 |
|
117 |
117 |
$866.58 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
901 |
846 |
$866.29 |
| 87899 |
|
175 |
173 |
$860.24 |
| G0008 |
Administration of influenza virus vaccine |
81 |
79 |
$829.02 |
| J2785 |
Injection, regadenoson, 0.1 mg |
12 |
12 |
$822.25 |
| C9113 |
Injection, pantoprazole sodium, per vial |
712 |
429 |
$768.96 |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
604 |
553 |
$746.98 |
| 74420 |
|
26 |
24 |
$731.95 |
| 29125 |
|
65 |
65 |
$702.52 |
| 85008 |
|
3,548 |
3,335 |
$682.70 |
| J1815 |
Injection, insulin, per 5 units |
43 |
33 |
$676.80 |
| 90785 |
|
20 |
13 |
$675.15 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
391 |
323 |
$632.84 |
| 29126 |
|
45 |
42 |
$631.53 |
| P9612 |
Catheterization for collection of specimen, single patient, all places of service |
2,357 |
2,333 |
$626.77 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
466 |
424 |
$616.26 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
1,586 |
1,494 |
$570.62 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
27 |
26 |
$517.52 |
| 86920 |
|
14 |
13 |
$512.57 |
| 90715 |
|
48 |
48 |
$512.47 |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
61 |
61 |
$506.17 |
| J2310 |
Injection, naloxone hydrochloride, per 1 mg |
84 |
75 |
$479.32 |
| 78580 |
|
13 |
13 |
$478.58 |
| C1729 |
Catheter, drainage |
188 |
169 |
$470.65 |
| 87073 |
|
372 |
341 |
$467.91 |
| 88341 |
|
30 |
26 |
$458.37 |
| 72072 |
|
14 |
12 |
$455.12 |
| 76937 |
|
15 |
14 |
$443.02 |
| L1906 |
Ankle foot orthosis, multiligamentous ankle support, prefabricated, off-the-shelf |
219 |
216 |
$441.31 |
| J1920 |
Injection, labetalol hydrochloride, 5 mg |
48 |
44 |
$436.59 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
947 |
868 |
$420.92 |
| 87185 |
|
117 |
113 |
$417.89 |
| J1953 |
Injection, levetiracetam, 10 mg |
736 |
580 |
$412.14 |
| 86780 |
|
108 |
96 |
$395.65 |
| 86317 |
|
54 |
54 |
$387.74 |
| 86703 |
|
42 |
41 |
$360.90 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
356 |
330 |
$340.74 |
| L1830 |
Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf |
77 |
71 |
$308.53 |
| 77061 |
|
298 |
227 |
$293.64 |
| 86308 |
|
199 |
195 |
$282.40 |
| 74019 |
|
14 |
14 |
$256.50 |
| 82731 |
|
14 |
13 |
$236.40 |
| 83655 |
|
25 |
25 |
$202.17 |
| J0153 |
Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) |
21 |
14 |
$198.41 |
| C1758 |
Catheter, ureteral |
42 |
36 |
$156.64 |
| 88112 |
|
17 |
13 |
$147.58 |
| L8699 |
Prosthetic implant, not otherwise specified |
93 |
89 |
$141.71 |
| A9576 |
Injection, gadoteridol, (prohance multipack), per ml |
123 |
121 |
$138.11 |
| J0571 |
Buprenorphine, oral, 1 mg |
110 |
42 |
$125.62 |
| J1836 |
Injection, metronidazole, 10 mg |
273 |
180 |
$118.05 |
| 91300 |
|
3,848 |
3,354 |
$110.00 |
| 83550 |
|
15 |
15 |
$101.80 |
| 73660 |
|
14 |
14 |
$81.03 |
| 84481 |
|
16 |
12 |
$79.59 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
77 |
67 |
$79.44 |
| 84112 |
|
13 |
13 |
$78.49 |
| J0736 |
Injection, clindamycin phosphate, 300 mg |
83 |
62 |
$77.79 |
| 76377 |
|
13 |
13 |
$59.94 |
| 91307 |
|
426 |
359 |
$58.00 |
| A4605 |
Tracheal suction catheter, closed system, each |
51 |
49 |
$57.25 |
| A9270 |
Non-covered item or service |
3,774 |
2,702 |
$55.58 |
| 82009 |
|
36 |
34 |
$54.56 |
| A9540 |
Technetium tc-99m macroaggregated albumin, diagnostic, per study dose, up to 10 millicuries |
14 |
13 |
$42.05 |
| 85660 |
|
12 |
12 |
$42.00 |
| 82553 |
|
15 |
12 |
$41.25 |
| J7510 |
Prednisolone oral, per 5 mg |
140 |
130 |
$27.67 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
280 |
224 |
$23.85 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
98 |
87 |
$22.88 |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
103 |
98 |
$22.04 |
| 87150 |
|
14 |
12 |
$18.43 |
| 85370 |
|
13 |
13 |
$15.34 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
74 |
57 |
$13.91 |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
16 |
12 |
$13.04 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
48 |
39 |
$12.72 |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
37 |
12 |
$12.53 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
18 |
18 |
$10.20 |
| J7121 |
5% dextrose in lactated ringers infusion, up to 1000 cc |
13 |
12 |
$8.25 |
| 85007 |
|
724 |
663 |
$6.94 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
61 |
49 |
$6.30 |
| 91305 |
|
271 |
255 |
$4.00 |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
73 |
73 |
$2.00 |
| Q0244 |
Injection, casirivimab and imdevimab, 1200 mg |
13 |
13 |
$0.00 |
| 88302 |
|
13 |
13 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
12 |
12 |
$0.00 |
| OP450 |
|
29 |
27 |
$0.00 |
| A9503 |
Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries |
13 |
13 |
$0.00 |